P1643: FIBRIN CLOT PROPERTIES IDENTIFY PATIENTS THAT BENEFIT FROM CATHETER-DIRECTED THROMBOLYSIS: A POST HOC ANALYSIS OF THE CAVA TRIAL

• Aaron F.J. Iding,
• Alkarithi Ghadir,
• Hugo Ten Cate,
• Robert A.S. Ariëns,
• Arina J. Ten Cate-Hoek

Affiliations

Aaron F.J. Iding

1 Maastricht University Medical Center, Heart & Vascular Center, Thrombosis Expertise Center, Maastricht, The Netherlands

Alkarithi Ghadir

3 University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Discovery and Translational Science Department, Leeds, United Kingdom

Hugo Ten Cate

1 Maastricht University Medical Center, Heart & Vascular Center, Thrombosis Expertise Center, Maastricht, The Netherlands

Robert A.S. Ariëns

3 University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Discovery and Translational Science Department, Leeds, United Kingdom

Arina J. Ten Cate-Hoek

1 Maastricht University Medical Center, Heart & Vascular Center, Thrombosis Expertise Center, Maastricht, The Netherlands